Today: 20 May 2026
VeriSign stock dives nearly 10% after outlook, costs take the shine off results
6 February 2026
1 min read

VeriSign stock dives nearly 10% after outlook, costs take the shine off results

New York, February 6, 2026, 15:10 EST — Regular session

  • VeriSign shares dropped nearly 9.5% on Friday, deepening the selloff that followed its latest quarterly report.
  • The domain registry operator bumped up its quarterly dividend and confirmed it’s still spending big on buybacks.
  • 2026 guidance, .com pricing rules, and the ongoing timeline for the .web dispute are drawing close investor attention.

VeriSign shares dropped close to 10% Friday, lagging behind a broader market that moved higher in afternoon trading.

VeriSign generally trades like a dependable toll booth operator for .com and .net domains, so a drop like this stands out. Such a sharp move often flags to traders that something’s changed—whether it’s growth prospects, cost dynamics, or expectations for cash returns.

VeriSign’s “domain name base”—that’s the total count of .com and .net addresses on its books—gets close investor attention. Even minor shifts in renewal rates can show up in the top line.

The company turned in fourth-quarter revenue of $425 million late Thursday, with net income landing at $206 million. For all of 2025, revenue climbed to $1.66 billion. The board bumped the quarterly dividend up 5.2% to $0.81 a share. In total, $1.1 billion was returned to shareholders during 2025, via dividends and buybacks.

During the call, management pegged 2026 revenue between $1.715 billion and $1.735 billion, with operating income targeted at $1.16 billion to $1.18 billion. They’re looking for domain base growth to land somewhere between 1.5% and 3.5%. CFO John Calys flagged an impairment charge related to real estate the company plans to offload, and added that interest income forecasts have come down as both rates and cash balances ease.

VeriSign, in its latest annual report, spelled out the strict limits around pricing. The company bumped up the .com wholesale rate to $10.26 back in September 2024, pointing to registry rules that only let prices rise under a specific cap. Registrars, not VeriSign, decide what customers actually pay. For the .web arbitration, post-hearing briefs should land sometime in the first half of 2026.

Eyes turn to the close as traders gauge if Friday’s selloff finds its footing. The next test: How soon analysts and major holders shift attention from the buyback and dividend to what the 2026 margin profile might signal.

There’s a risk here. If small businesses pull back on discretionary spending, domain growth could stall. Renewal rates may also dip once previous signups face their first renewal. Pricing? That’s tangled in politics. VeriSign can only raise .com fees through ICANN’s process, plus there’s that separate agreement with the U.S. government hanging over the whole arrangement.

Now attention shifts to February 19, the dividend record date, with payouts set for February 27. The .web briefing, scheduled for the first half of 2026, is still on the radar as investors hunt for signs of possible new growth levers.

Stock Market Today

  • Wall Street Price Targets: Lululemon Rated Buy, Hormel and Walker & Dunlop Marked Sell for May 2026
    May 20, 2026, 4:23 AM EDT. A recent StockStory analysis highlights Wall Street price targets for May 2026, identifying one stock recommended to buy and two to sell. Lululemon (NASDAQ:LULU) is rated a buy with a projected 47.9% return, supported by strong fundamentals. Conversely, Hormel Foods (NYSE:HRL), known for SPAM, and Walker & Dunlop (NYSE:WD) face selling pressure despite upside targets of 33.2% and 29.6%, respectively. Hormel battles declining unit sales and shrinking earnings, while Walker & Dunlop suffers from falling net interest income and equity erosion. Investors should weigh these fundamentals against price target optimism before making decisions.

Latest articles

Meiwu Technology Stock Jumps Again After 97% Surge: Why WNW Is Moving Now

Meiwu Technology Stock Jumps Again After 97% Surge: Why WNW Is Moving Now

20 May 2026
New York, May 20, 2026, 04:12 EDT Meiwu Technology Company Limited shares were bid higher before the bell on Wednesday, extending a sharp rally that nearly doubled the Nasdaq-listed stock in the prior session. WNW closed Tuesday at $4.75, up 97.10%, after trading between $3.70 and $6.39 on volume of about 51.9 million shares. In premarket trade — the early-hours session before regular U.S. trading — the stock was quoted at $5.31, up 11.79%, at 4:09 a.m. EDT. The move matters now because the rally is coming just days after Meiwu disclosed fresh financing tied to a planned AI skincare
Astera Labs Stock Surges: The AI Networking Bet Traders Are Chasing Before Nvidia Results

Astera Labs Stock Surges: The AI Networking Bet Traders Are Chasing Before Nvidia Results

20 May 2026
Astera Labs shares rose 13.3% to $244.26 on Tuesday after management outlined a faster ramp for its Scorpio X fabric switches and optical networking tied to Nvidia’s NVLink Fusion. The move followed presentations at J.P. Morgan’s tech conference and comes ahead of Nvidia’s earnings Wednesday. Astera’s first-quarter revenue jumped 93% to $308.4 million, with second-quarter guidance above analyst forecasts.
Snowflake Shares Rise Ahead of Results With AI Demand in Focus

Snowflake Shares Rise Ahead of Results With AI Demand in Focus

20 May 2026
Snowflake shares climbed 3.2% to $169.55 Tuesday after BofA Securities raised its price target to $205 and predicted strong fiscal Q1 results next week. Mizuho Securities channel checks indicated continued demand for Snowflake’s data and AI products. The company reports earnings after the market closes May 27. Recent deals include a $400 million contract and partnerships with OpenAI and Anthropic.
Exxon Mobil stock price jumps as XOM shrugs off softer oil — what traders watch next
Previous Story

Exxon Mobil stock price jumps as XOM shrugs off softer oil — what traders watch next

Molina Healthcare stock dives 27% after 2026 profit outlook reset; Medicare Advantage exit looms
Next Story

Molina Healthcare stock dives 27% after 2026 profit outlook reset; Medicare Advantage exit looms

Go toTop